• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

医院获得性肺炎和呼吸机相关性肺炎管理的国际临床指南摘要

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

作者信息

Torres Antoni, Niederman Michael S, Chastre Jean, Ewig Santiago, Fernandez-Vandellos Patricia, Hanberger Hakan, Kollef Marin, Li Bassi Gianluigi, Luna Carlos M, Martin-Loeches Ignacio, Paiva J Artur, Read Robert C, Rigau David, François Timsit Jean, Welte Tobias, Wunderink Richard

机构信息

Dept of Pulmonology, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERES Barcelona, Barcelona, Spain.

Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA.

出版信息

ERJ Open Res. 2018 Jun 26;4(2). doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

DOI:10.1183/23120541.00028-2018
PMID:
29977898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6018155/
Abstract

http://ow.ly/S3zA30iZfLa.

摘要

这看起来是一个网址链接，无法直接翻译为中文，保留原文：http://ow.ly/S3zA30iZfLa.

相似文献

1
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.医院获得性肺炎和呼吸机相关性肺炎管理的国际临床指南摘要
ERJ Open Res. 2018 Jun 26;4(2). doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.
2
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).国际 ERS/ESICM/ESCMID/ALAT 医院获得性肺炎和呼吸机相关性肺炎管理指南：欧洲呼吸学会 (ERS)、欧洲重症监护医学学会 (ESICM)、欧洲临床微生物学和传染病学会 (ESCMID) 和拉丁美洲胸科协会 (ALAT) 医院获得性肺炎 (HAP)/呼吸机相关性肺炎 (VAP) 管理指南。
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
3
Treating nosocomial pneumonia: what's new.医院获得性肺炎的治疗：有哪些新进展。
ERJ Open Res. 2018 Jun 26;4(2). doi: 10.1183/23120541.00058-2018. eCollection 2018 Apr.
4
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.欧洲呼吸学会/欧洲重症监护医学学会/欧洲临床微生物学与传染病学会/拉丁美洲胸科协会严重社区获得性肺炎管理指南
Eur Respir J. 2023 Apr 3;61(4). doi: 10.1183/13993003.00735-2022. Print 2023 Apr.
5
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.ERS/ESICM/ESCMID/ALAT 指南：严重社区获得性肺炎管理。
Intensive Care Med. 2023 Jun;49(6):615-632. doi: 10.1007/s00134-023-07033-8. Epub 2023 Apr 4.
6
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.医院获得性肺炎/呼吸机相关性肺炎新指南：美国与欧洲的比较。
Curr Opin Crit Care. 2018 Oct;24(5):347-352. doi: 10.1097/MCC.0000000000000535.
7
Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.更正：欧洲呼吸学会/欧洲重症监护医学学会/欧洲临床微生物与感染性疾病学会/拉丁美洲胸科协会重症社区获得性肺炎管理指南
Intensive Care Med. 2023 Aug;49(8):1040-1041. doi: 10.1007/s00134-023-07082-z.
8
Ventilator-associated pneumonia: new principles guiding empiric antibiotic therapy.呼吸机相关性肺炎：指导经验性抗生素治疗的新原则。
Curr Opin Infect Dis. 2020 Apr;33(2):182-188. doi: 10.1097/QCO.0000000000000640.
9
Defining, treating and preventing hospital acquired pneumonia: European perspective.定义、治疗及预防医院获得性肺炎：欧洲视角
Intensive Care Med. 2009 Jan;35(1):9-29. doi: 10.1007/s00134-008-1336-9. Epub 2008 Nov 7.
10
Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study.快速多重聚合酶链反应对重症监护病房呼吸机相关性肺炎患者抗菌治疗指导的潜在影响：一项前瞻性观察性临床和经济学研究。
Front Cell Infect Microbiol. 2022 Apr 13;12:804611. doi: 10.3389/fcimb.2022.804611. eCollection 2022.

引用本文的文献

1
Associations Between Candida and , and Species as Ventilator-Associated Pneumonia Isolates in 84 Cohorts of ICU Patients.念珠菌与[未提及的两种菌]以及84个重症监护病房患者队列中作为呼吸机相关性肺炎分离株的[具体菌名]之间的关联。
Microorganisms. 2025 May 22;13(6):1181. doi: 10.3390/microorganisms13061181.
2
A comparison of frequentist and Bayesian approaches to the Personalised Randomised Controlled Trial (PRACTical)-design and analysis considerations.频率学派与贝叶斯学派在个性化随机对照试验（PRACTical）设计与分析考量方面的比较
BMC Med Res Methodol. 2025 May 29;25(1):149. doi: 10.1186/s12874-025-02537-x.
3
Ventilator-associated pneumonia rates in a level I trauma intensive care unit in KwaZulu-Natal Province, South Africa, compared with international benchmarks.

本文引用的文献

1
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).国际 ERS/ESICM/ESCMID/ALAT 医院获得性肺炎和呼吸机相关性肺炎管理指南：欧洲呼吸学会 (ERS)、欧洲重症监护医学学会 (ESICM)、欧洲临床微生物学和传染病学会 (ESCMID) 和拉丁美洲胸科协会 (ALAT) 医院获得性肺炎 (HAP)/呼吸机相关性肺炎 (VAP) 管理指南。
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
2
The current status of biomarkers for the diagnosis of nosocomial pneumonias.目前用于诊断医院获得性肺炎的生物标志物。
Curr Opin Crit Care. 2017 Oct;23(5):391-397. doi: 10.1097/MCC.0000000000000442.
南非夸祖鲁-纳塔尔省一家一级创伤重症监护病房的呼吸机相关性肺炎发生率与国际基准的比较。
South Afr J Crit Care. 2024 Nov 25;40(3):e1967. doi: 10.7196/SAJCC.2024.v40i3.1967. eCollection 2024.
4
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.一种用于鉴别小儿肺炎病毒和细菌病因的五转录本特征。
iScience. 2025 Jan 4;28(2):111747. doi: 10.1016/j.isci.2025.111747. eCollection 2025 Feb 21.
5
Polymyxin B Peptide Hydrogel Coating: A Novel Approach to Prevent Ventilator-Associated Pneumonia.多粘菌素 B 肽水凝胶涂层：预防呼吸机相关性肺炎的新方法。
Int J Mol Sci. 2024 Sep 24;25(19):10269. doi: 10.3390/ijms251910269.
6
Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy.预测意大利重症监护病房感染碳青霉烯类耐药革兰氏阴性病原体患者的早期适当治疗。
Antimicrob Resist Infect Control. 2024 Aug 26;13(1):91. doi: 10.1186/s13756-024-01452-y.
7
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007.德国成人医院获得性肺炎国家指南要点总结 - 2024年更新 联邦联合委员会（G-BA）资助编号：01VSF22007
Infection. 2024 Dec;52(6):2531-2545. doi: 10.1007/s15010-024-02358-y. Epub 2024 Aug 8.
8
Efficacy of an Herbal Preparation (Atomy's HemoHIM) against Ventilator-associated Pneumonia: A Randomized Controlled Clinical Trial.一种草药制剂（爱多美Hemohim）对呼吸机相关性肺炎的疗效：一项随机对照临床试验。
J Res Pharm Pract. 2024 Jan 31;12(2):58-63. doi: 10.4103/jrpp.jrpp_9_23. eCollection 2023 Apr-Jun.
9
Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Literature Review.医院获得性肺炎和呼吸机相关性肺炎：文献综述
Microorganisms. 2024 Jan 20;12(1):213. doi: 10.3390/microorganisms12010213.
10
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by .美罗培南治疗医院获得性肺炎的分子药效动力学。
mBio. 2024 Feb 14;15(2):e0316523. doi: 10.1128/mbio.03165-23. Epub 2024 Jan 18.
3
Biomarker-guided antibiotic therapy-strengths and limitations.生物标志物引导的抗生素治疗——优势与局限
Ann Transl Med. 2017 May;5(10):208. doi: 10.21037/atm.2017.04.04.
4
Associations Between Ventilator Bundle Components and Outcomes.呼吸机捆绑治疗组件与治疗结果的关联
JAMA Intern Med. 2016 Sep 1;176(9):1277-83. doi: 10.1001/jamainternmed.2016.2427.
5
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.成人医院获得性肺炎和呼吸机相关性肺炎的管理：美国感染病学会和美国胸科学会2016年临床实践指南
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
6
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.降钙素原指导在危重症患者中缩短抗生素治疗时间的疗效和安全性：一项随机、对照、开放标签试验。
Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.
7
Serum Procalcitonin Level and Mortality Risk in Critically ill Patients with Ventilator-Associated Pneumonia.机械通气相关性肺炎重症患者的血清降钙素原水平与死亡风险
Cell Physiol Biochem. 2015;37(5):1967-72. doi: 10.1159/000438557. Epub 2015 Nov 20.
8
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.重症成年患者医院获得性肺炎的短疗程与长疗程抗生素治疗
Cochrane Database Syst Rev. 2015 Aug 24;2015(8):CD007577. doi: 10.1002/14651858.CD007577.pub3.
9
Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.社区获得性肺炎中与潜在抗生素耐药病原体相关的危险因素。
Ann Am Thorac Soc. 2015 Feb;12(2):153-60. doi: 10.1513/AnnalsATS.201407-305OC.
10
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.重症监护病房（ICU）获得性肺炎的耐药模式和结果。欧洲疾病预防控制中心（ECDC）和疾病控制与预防中心（CDC）分类的多药耐药生物体的验证。
J Infect. 2015 Mar;70(3):213-22. doi: 10.1016/j.jinf.2014.10.004. Epub 2014 Oct 27.